


Kashiv BioSciences Email Formats
Pharmaceutical Manufacturing • Bridgewater, New Jersey, United States • 201-500 Employees
Kashiv BioSciences Email Formats
Kashiv BioSciences uses 3 email formats. The most common is {first name}.{last name} (e.g., john.doe@kashivindia.com), used 96.9% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}.{last name} | john.doe@kashivindia.com | 96.9% |
{first initial}.{last name} | j.doe@kashivindia.com | 1% |
{first initial}{last name} | jdoe@kashivpharma.com | 1% |
Key Contacts at Kashiv BioSciences
Sandeep Athalye
Chief Executive Officer
Prayag N. Shah Clinical Development
Sr. Director & Head Global Clinical Affairs/Medical Affairs
Ashish Awasthi
Director Of Engineering
Apar Dholakia
Sr. Director Of Manufacturing Operations
Rajat Desai
Director Of Operations
Lilian Y. Shapiama
Director, Qa
Harsha V Prasad
Associate Director -Quality
Kaumil Bhavsar
Associate Director, Upstream Process
Russell Ivanov
Director, Corporate Compliance
Kristy Winters Francisco
Director Of Quality
Company overview
| Headquarters | 995 US Highway 202/206, Bridgewater, New Jersey 08807, US |
| Phone number | +17326453031 |
| Website | |
| NAICS | 3254 |
| Keywords | Biomaxx®, Fast Acting Sublingual Technology (Fast™), Long-Acting Depot Injections (Load™) |
| Employees | 201-500 |
| Socials |
About Kashiv BioSciences
Kashiv BioSciences, LLC is a fully integrated biosciences company headquartered in Bridgewater, New Jersey with locations in Piscataway, NJ, Chicago IL, and Ahmedabad, India. Kashiv BioSciences’ broad business offering includes drug delivery platforms incorporating delayed release technology and gastric retention systems that improve the efficacy and safety of known drugs, a 505(b)(2) pipeline of development products targeting unmet clinical needs, biosimilars and prodrugs. Additionally, as part of a development collaboration Kashiv BioSciences has approved generic products and products in advanced stages of development, including several complex generic products. Kashiv BioSciences’ medications will improve the lives of patients suffering from cancer as well as neuromuscular, movement and endocrine disorders, among other debilitating conditions, both in the U.S. and globally. The combined breadth of expertise in small and large molecules, peptides, proteins and monoclonal antibodies enables Kashiv BioSciences to develop products with meaningful clinical differentiation and a compelling value proposition for patients, physicians and payers.
Employees by Management Level
Total employees: 201-500
Seniority
Employees
Employees by Department
Kashiv BioSciences has 132 employees across 10 departments.
Departments
Number of employees
Funding Data
Explore Kashiv BioSciences's funding history, including investment rounds, total capital raised, and key backers.
Frequently asked questions
4.8
40,000 users



